Cardio Diagnostics Holdings, Inc. a pioneering AI-driven precision cardiovascular medicine company by UI faculty Dr. Robert Philibert and UI graduate Dr. Meesha Dogan, today announced that India’s Patent Office has granted a patent to the University of Iowa Research Foundation titled “A Kit for Determining Methylation Status of a CpG Dinucleotide and a Genotype of a Single Nucleotide Polymorphism."

Lantheus Holdings, Inc. today announced it has entered into multiple strategic agreements with Perspective Therapeutics, Inc., co-founded by UI Professor Mark Schultz and Dr. Frances Johnson, a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body.

Lyle and Sharon Bighley Chair and Professor Aliasger Salem has been named a Fellow of the National Academy of Inventors (NAI). Election as an Academy Fellow is the highest professional distinction awarded solely to inventors.

The Innovation Challenge will bring $225,000 in total funding during the 2023-24 academic year across the University of Iowa's campus. The Challenge is a university-wide competition with the goal to identify, advance and support the most innovative and entrepreneurial projects on campus.

Please join UIRF at the upcoming innovation day, October 10th, at the Stanley Hydraulics Lab. Agenda includes educational sessions on intellectual property and information for graduate students and post-docs. Lunch provided!

Established in 2020, Equalize is a comprehensive program designed to take national action around the disparity of women academic inventors forming university startups. Equalize participants receive education, a field-specific mentor, and access to networks that drive new entrepreneurial connections. If you would like to participate or have any questions, please feel free to reach out to a licensing associate.

hC Bioscience, co-founded by UI Faculty Dr. Chrisopher Ahern, has moved and consolidated its team to a new biotech-dedicated facility located in Boston's Seaport. The office, situated at 645 Summer Street, Suite 102, will serve as an important hub for hC Bioscience's continued growth and innovation in the field of tRNA.

As part of his work in high-energy particle physics, Prof. Yasar Onel and his team have invented a scintillator that would be used in an ultra-fast radiation treatment for cancer.

Inventions of two University of Iowa College of Engineering faculty members have been licensed for commercial use. They are the latest technology transfer examples in which research emerging from UI laboratories is spun-out to a private company for broader public benefit.

Perspective, Therapeutics, Inc., a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents based in-part on IP licensed from UIRF, and an innovator in seed brachytherapy powering expanding treatment options for multiple cancers, announced the presentation of extremely encouraging results regarding 212Pb-VMT-α-NET, its lead preclinical candidate for neuroendocrine tumors (NET), currently being used therapeutically in India on a compassionate use basis.